EchoStar Corporation Common Stock vs Immunovant Inc. Common Stock — how do they compare? EchoStar Corporation Common Stock trades at $94.64 (market cap $27.15B), while Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B). The key difference: EchoStar Corporation Common Stock is far larger — about 4.3× Immunovant Inc. Common Stock's market cap, and Immunovant Inc. Common Stock is trading nearer its 52-week high, EchoStar Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EchoStar Corporation Common Stock for 1 Days and Immunovant Inc. Common Stock for 1 Days on average.
| ECHO | IMVT | |
|---|---|---|
Market Cap | $27.15B | $6.25B |
Volume | 4,944,235 | 1,755,411 |
Sector | Media | Health |
52-Week High | $141.80 | $44.96 |
52-Week Low | $66.93 | $17.03 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $44.21B | $5.35B |
Trailing returns across standard periods
EchoStar provides satellite communications and connectivity services. Its businesses support broadband, enterprise, government, and consumer communications needs.
Read more on ECHO →Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →